🔗 Share this article

Treasury head Rachel Reeves has announced she is preparing "targeted measures to address household expense issues" in the upcoming financial statement.

Speaking to media outlets, she emphasized that lowering inflation is a collective task of both the government and the Bank of England.

The United Kingdom's inflation rate is expected to be the most elevated among the Group of Seven developed nations this year and next.

Potential Utility Bill Interventions

It is understood the administration could intervene to reduce utility costs, for instance by slashing the current 5% level of value-added tax charged on energy.

Another option is to lower some of the government charges currently included in bills.

Fiscal Limitations and Analyst Expectations

The government will obtain the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for these actions.

The consensus from most economists is that the Chancellor will have to introduce tax rises or expenditure reductions in order to meet her self-imposed borrowing rules.

Earlier on the same day, calculations indicated there was a £22bn deficit for the Treasury chief to fill, which is at the more modest range of expectations.

"It is a joint responsibility between the Bank of England and the government to continue tackling some of the drivers of inflation," Reeves told the BBC in the US capital, at the conferences of the IMF and World Bank.

Tax Commitments and Global Concerns

While a great deal of the attention has been on probable tax increases, the chancellor said the latest figures from the OBR had not altered her vow to election pledges not to increase tax levels on earnings tax, VAT or social security contributions.

She attributed an "unpredictable global environment" with rising geopolitical and commercial tensions for the fiscal tax moves, probably to be targeted on those "wealthiest."

International Economic Tensions

Referring to apprehensions about the UK's economic relations with the Asian nation she said: "The UK's national security invariably take priority."

Last week's declaration by Chinese authorities to increase export controls on rare earths and other resources that are key for high-technology production led US President Donald Trump to suggest an additional 100% tariff on goods from the Asian country, raising the risk of an all-out trade war between the two global powers.

The US Treasury Secretary labeled China's decision "commercial pressure" and "a global supply chain control attempt."

Asked about considering the American proposal to participate in its conflict with the Asian nation, Reeves said she was "extremely troubled" by Chinese actions and urged the Chinese government "not to put up barriers and limit trade."

She said the move was "bad for the international commerce and creates additional headwinds."

"It is my opinion there are areas where we should address China, but there are also significant opportunities to trade with Chinese markets, including financial services and other areas of the economic system. We've got to maintain that balance right."

The chancellor also affirmed she was collaborating with international partners "regarding our own critical minerals strategy, so that we are reduced dependence."

Health Service Medicine Costs and Investment

The Chancellor also acknowledged that the cost the NHS spends on medicines could go up as a consequence of current talks with the Trump administration and its drugs companies, in exchange for lower tariffs and capital.

Some of the world's largest pharmaceutical manufacturers have said lately that they are either pausing or canceling projects in the UK, with some attributing the low prices they are getting.

Recently, the Science Minister said the price the health service spends on drugs would must rise to halt firms and drug research funding departing from the UK.

The Chancellor told media: "We have seen due to the cost structure, that clinical trials, new drugs have not been available in the United Kingdom in the way that they are in other continental states."

"We want to ensure that patients receiving treatment from the National Health Service are able to receive the best essential drugs in the globe. And so we are looking at this situation, and... looking to secure more investment into the UK."